- Home
- SLS vs EVC Comparison
SLS vs EVC Comparison
Compare SLS & EVC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SLS
- EVC
- Stock Information
- Founded
- SLS 2012
- EVC 1996
- Country
- SLS United States
- EVC United States
- Employees
- SLS N/A
- EVC N/A
- Industry
- SLS Biotechnology: Pharmaceutical Preparations
- EVC Broadcasting
- Sector
- SLS Health Care
- EVC Industrials
- Exchange
- SLS Nasdaq
- EVC Nasdaq
- Market Cap
- SLS 169.6M
- EVC 171.0M
- IPO Year
- SLS N/A
- EVC 2000
- Fundamental
- Price
- SLS $1.71
- EVC $2.07
- Analyst Decision
- SLS
- EVC
- Analyst Count
- SLS 0
- EVC 0
- Target Price
- SLS N/A
- EVC N/A
- AVG Volume (30 Days)
- SLS 2.9M
- EVC 182.2K
- Earning Date
- SLS 05-13-2025
- EVC 05-08-2025
- Dividend Yield
- SLS N/A
- EVC 9.52%
- EPS Growth
- SLS N/A
- EVC N/A
- EPS
- SLS N/A
- EVC N/A
- Revenue
- SLS N/A
- EVC $378,623,000.00
- Revenue This Year
- SLS N/A
- EVC $64.06
- Revenue Next Year
- SLS N/A
- EVC N/A
- P/E Ratio
- SLS N/A
- EVC N/A
- Revenue Growth
- SLS N/A
- EVC 23.10
- 52 Week Low
- SLS $0.77
- EVC $1.58
- 52 Week High
- SLS $2.12
- EVC $2.73
- Technical
- Relative Strength Index (RSI)
- SLS 54.26
- EVC 62.90
- Support Level
- SLS $1.36
- EVC $1.85
- Resistance Level
- SLS $2.12
- EVC $2.04
- Average True Range (ATR)
- SLS 0.18
- EVC 0.08
- MACD
- SLS -0.01
- EVC 0.02
- Stochastic Oscillator
- SLS 46.05
- EVC 86.67
About SLS SELLAS Life Sciences Group Inc.
SELLAS Life Sciences Group Inc is a late-stage clinical biopharmaceutical company focused on the development of novel therapeutics for a broad range of cancer indications. The company's product candidates currently include galinpepimut-S, or GPS, a peptide immunotherapy directed against the Wilms tumor 1, or WT1, antigen, and GFH009, a selective small molecule cyclin-dependent kinase 9, or CDK9, inhibitor.
About EVC Entravision Communications Corporation
Entravision Communications Corp owns and operates Spanish language television and radio stations in the United States. The Company also owns and operates a smaller group of television stations that broadcast English language programming and has operations that provide programmatic advertising technology and services. The Company has organized its operations into two reportable segments. Its media segment includes its television, radio, and digital marketing operations. Its advertising and technology services segment provides programmatic advertising and technology services. The company generates the majority of its revenue from the Media segment. Geographically, the company generates the majority of its revenue from the United States.